Free tool
Healthcare stocks
We cover 11 companies in the Healthcare sector. The median market value in the group is $43.01B. Across the group, the median move over the past trading day is +2.23%. Price change over the past year runs from −5.9% to +129.8% across the middle 80 percent of the group, with a median of +15.6%.
Other lists in this group
Table
11 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.